ID	Description	GeneRatio	BgRatio	pvalue	p.adjust	qvalue	geneID	Count
hsa04512	ECM-receptor interaction	21/157	89/8577	3.79038306235313e-18	6.02670906914147e-16	4.70805475113336e-16	341640/158326/80144/3918/3381/7148/1287/3339/3915/3911/284217/1311/10319/3909/3371/375790/6696/3912/3914/1292/3910	21
hsa04060	Cytokine-cytokine receptor interaction	31/157	297/8577	1.3685507489108e-15	1.08799784538409e-13	8.49942044060391e-14	9518/3552/27189/3600/146433/7124/3596/6366/8742/5196/6351/10148/1440/1489/8743/4803/6376/9547/10220/7040/6358/2056/3976/23529/2920/4050/3626/6352/3589/6348/8741	31
hsa04151	PI3K-Akt signaling pathway	29/157	359/8577	9.12793692441352e-12	4.83780656993916e-10	3.77928616519577e-10	2254/3918/3381/80310/7148/1287/5154/8817/1440/3915/3479/3911/285/284217/4803/1311/10319/56034/2056/7423/3909/3481/3371/9048/6696/3912/3914/1292/3910	29
hsa04510	Focal adhesion	21/157	203/8577	9.62450283325047e-11	3.82573987621706e-09	2.98866140611462e-09	3918/3381/80310/7148/1287/5154/3915/3479/3911/284217/1311/10319/56034/7423/3909/3371/6696/3912/3914/1292/3910	21
hsa05146	Amoebiasis	13/157	102/8577	3.61122492713229e-08	1.14836952682807e-06	8.971042976876e-07	7124/3918/1287/3915/3911/284217/10319/7040/3909/2920/3912/3914/3910	13
hsa04610	Complement and coagulation cascades	12/157	86/8577	4.41560687347484e-08	1.17013582147083e-06	9.14108089596545e-07	2161/713/2147/714/2159/5054/710/2244/5345/712/5104/2162	12
hsa04061	Viral protein interaction with cytokine and cytokine receptor	12/157	100/8577	2.43299409779212e-07	5.5263723078421e-06	4.31719253442812e-06	146433/7124/6366/5196/6351/8743/6376/9547/6358/2920/6352/6348	12
hsa05323	Rheumatoid arthritis	11/157	93/8577	9.11744418310954e-07	1.81209203139302e-05	1.41560317579859e-05	3552/3600/7124/1513/7040/2920/4050/6352/3589/6348/8741	11
hsa05165	Human papillomavirus infection	20/157	331/8577	2.34428730160442e-06	4.05278650114503e-05	3.16602983869655e-05	7124/3918/3381/7148/1287/3915/7483/3911/284217/1311/10319/54361/3909/7474/3371/6696/3912/3914/1292/3910	20
hsa04974	Protein digestion and absorption	11/157	103/8577	2.54892232776417e-06	4.05278650114503e-05	3.16602983869655e-05	1290/7373/1287/2006/136227/1303/81578/80781/85301/50509/1292	11
hsa05145	Toxoplasmosis	11/157	111/8577	5.33307762548821e-06	7.70872129502387e-05	6.02203980677138e-05	7124/3918/3915/3911/284217/10319/7040/3909/3912/3914/3910	11
hsa05222	Small cell lung cancer	10/157	92/8577	6.30577103713599e-06	8.35514662420519e-05	6.52702616124603e-05	3918/1287/3915/3911/284217/10319/3909/3912/3914/3910	10
hsa05205	Proteoglycans in cancer	14/157	205/8577	2.19593153256078e-05	0.000268579318213203	0.000209813701086779	7124/10855/3339/3479/7483/4313/2817/7040/54361/7474/4060/3481/1634/6383	14
hsa04350	TGF-beta signaling pathway	10/157	108/8577	2.63570922927492e-05	0.000299341262467651	0.000233844878988301	79875/2200/10637/7124/8646/2331/7040/3626/1634/4052	10
hsa04657	IL-17 signaling pathway	9/157	94/8577	5.1703248094469e-05	0.000548054429801371	0.000428139177203322	27189/7124/3596/1440/727897/4586/2920/338324/6280	9
hsa04142	Lysosome	10/157	132/8577	0.000145926988381001	0.00145014944703619	0.00113285425190514	1520/5476/1513/1521/8692/1515/8372/1519/1509/1522	10
hsa04210	Apoptosis	10/157	136/8577	0.000186729781892564	0.00174647266593633	0.00136434144045341	7124/1520/8743/1513/1521/4803/1515/1519/1509/1522	10
hsa05142	Chagas disease	8/157	102/8577	0.00053905433447683	0.004761646621212	0.00371979014434304	713/7124/714/7040/5054/6352/712/6348	8
hsa04010	MAPK signaling pathway	14/157	301/8577	0.00121147516797221	0.010138134300399	0.00791989306485986	2254/3552/7124/80310/5154/8817/3479/285/4803/7040/56034/7423/3481/9048	14
hsa05218	Melanoma	6/157	72/8577	0.00197357668490869	0.0156899346450241	0.012256949937854	2254/80310/5154/8817/3479/56034	6
hsa05144	Malaria	5/157	50/8577	0.00210280871423868	0.0159212659792357	0.0124376655779531	7124/1440/1311/7040/6383	5
hsa04933	AGE-RAGE signaling pathway in diabetic complications	7/157	100/8577	0.00232248415226967	0.0167852263732217	0.0131125899506134	3552/7124/1287/4313/7040/5054/7423	7
hsa05133	Pertussis	6/157	76/8577	0.00260123047435632	0.0179824193662024	0.0140478350560204	713/3552/7124/714/710/712	6
hsa01521	EGFR tyrosine kinase inhibitor resistance	6/157	79/8577	0.00316240939219316	0.0209509622232797	0.0163668556262628	2621/80310/5154/3479/3084/56034	6
hsa04630	JAK-STAT signaling pathway	9/157	166/8577	0.00336671823839641	0.0214123279962012	0.0167272737739274	3600/3596/5154/1440/1489/2056/3976/23529/3589	9
hsa04066	HIF-1 signaling pathway	7/157	109/8577	0.0037719125214834	0.0230666958044562	0.0180196630580989	54583/3479/285/5054/2056/112398/7076	7
hsa04310	Wnt signaling pathway	9/157	171/8577	0.00409775602096428	0.0241312299012341	0.0188512752621359	4316/7483/5176/6422/54361/6424/7474/6425/84870	9
hsa00531	Glycosaminoglycan degradation	3/157	19/8577	0.00470084108849529	0.026694061895384	0.0208533552046032	10855/8692/8372	3
hsa04360	Axon guidance	9/157	182/8577	0.00614209695889127	0.0336756350504728	0.026307348136086	55558/9423/10509/10500/64218/54361/7474/54910/10512	9
hsa04970	Salivary secretion	6/157	93/8577	0.0070397856741872	0.0373108640731922	0.0291471827913716	1472/727897/1471/4586/1470/1469	6
hsa04062	Chemokine signaling pathway	9/157	192/8577	0.00861364065308821	0.0441796407690653	0.0345130593230699	6366/5196/6351/6376/9547/6358/2920/6352/6348	9
hsa04014	Ras signaling pathway	10/157	236/8577	0.0112981642235011	0.0561377534855209	0.0438547163938528	2254/80310/5154/8817/3479/285/4803/56034/7423/3481	10
hsa04620	Toll-like receptor signaling pathway	6/157	104/8577	0.0119039956901637	0.0573556155980616	0.0448061081798826	7124/6351/1513/6352/6696/6348	6
hsa04015	Rap1 signaling pathway	9/157	210/8577	0.0148817586736151	0.0695941067383765	0.0543667963927734	2254/80310/5154/8817/3479/285/4803/56034/7423	9
hsa04550	Signaling pathways regulating pluripotency of stem cells	7/157	143/8577	0.0158481296800143	0.0719957891177794	0.0562429865335847	10637/3479/7483/54361/3976/7474/3626	7
hsa04668	TNF signaling pathway	6/157	114/8577	0.0180476167952247	0.0797103075122425	0.0622695550244595	3600/7124/6376/3976/2920/6352	6
hsa05321	Inflammatory bowel disease	4/157	65/8577	0.0308904747812675	0.132745553789771	0.103700598127726	3552/7124/3596/7040	4
hsa04640	Hematopoietic cell lineage	5/157	99/8577	0.0349016422567658	0.146035818916468	0.114082930368376	3552/7124/1440/2056/3589	5
hsa04064	NF-kappa B signaling pathway	5/157	104/8577	0.041778450492885	0.167330997046801	0.130718686868736	7124/6366/6351/2920/4050	5
hsa05418	Fluid shear stress and atherosclerosis	6/157	139/8577	0.0420958483136606	0.167330997046801	0.130718686868736	3552/7124/5154/4313/2817/6383	6
hsa04928	Parathyroid hormone synthesis, secretion and action	5/157	106/8577	0.0447430381554078	0.173515684553899	0.135550154103674	10893/4325/64386/4326/4324	5
hsa05224	Breast cancer	6/157	147/8577	0.0527216019372078	0.199588921619429	0.155918522019813	2254/8817/3479/7483/54361/7474	6
hsa05226	Gastric cancer	6/157	149/8577	0.0556118942523528	0.205634678747072	0.16064145708146	2254/8817/7483/7040/54361/7474	6
hsa04672	Intestinal immune network for IgA production	3/157	49/8577	0.060150815390998	0.217363173799288	0.169803737228176	3600/7040/8741	3
hsa05171	Coronavirus disease - COVID-19	8/157	232/8577	0.062753005571486	0.221727286352584	0.173212974442932	713/7124/1440/2147/714/2244/712/2162	8
hsa05410	Hypertrophic cardiomyopathy	4/157	90/8577	0.0826530125172863	0.28569193457062	0.223182047529515	7124/3479/284217/7040	4
hsa05414	Dilated cardiomyopathy	4/157	96/8577	0.0990336201795647	0.335028629969166	0.261723789052377	7124/3479/284217/7040	4
hsa05215	Prostate cancer	4/157	97/8577	0.10190119951461	0.337547723392144	0.263691700498332	80310/5154/3479/56034	4
hsa05217	Basal cell carcinoma	3/157	63/8577	0.108199889085234	0.348950512420002	0.272599539659452	7483/54361/7474	3
hsa05310	Asthma	2/157	31/8577	0.109732865540881	0.348950512420002	0.272599539659452	7124/3596	2
hsa04936	Alcoholic liver disease	5/157	142/8577	0.118958345919651	0.370870137278911	0.289723112869325	713/7124/714/2920/712	5
hsa05211	Renal cell carcinoma	3/157	69/8577	0.132218131267824	0.404282362915077	0.315824686024356	54583/7040/112398	3
hsa05120	Epithelial cell signaling in Helicobacter pylori infection	3/157	70/8577	0.13639054723088	0.40917164169264	0.31964418218955	102/2920/6352	3
hsa05143	African trypanosomiasis	2/157	37/8577	0.146645384002205	0.431789186228715	0.337312969049906	7124/3910	2
hsa04150	mTOR signaling pathway	5/157	156/8577	0.157665663834433	0.455797100903179	0.35606791066915	7124/3479/7483/54361/7474	5
hsa04390	Hippo signaling pathway	5/157	157/8577	0.160611315799814	0.456021414503044	0.356243144067257	7483/7040/5054/54361/7474	5
hsa05140	Leishmaniasis	3/157	77/8577	0.166784308169705	0.465240438578651	0.363445029806559	3552/7124/7040	3
hsa05332	Graft-versus-host disease	2/157	42/8577	0.179040575475997	0.489396020954696	0.3823153291801	3552/7124	2
hsa04020	Calcium signaling pathway	7/157	253/8577	0.181599781360548	0.489396020954696	0.3823153291801	2254/80310/5154/8817/4803/56034/7423	7
hsa04940	Type I diabetes mellitus	2/157	43/8577	0.185648770993158	0.491969243131868	0.38432552591566	3552/7124	2
hsa05225	Hepatocellular carcinoma	5/157	168/8577	0.194420533009375	0.506768274565421	0.39588650379821	7483/7040/54361/7474/3481	5
hsa04380	Osteoclast differentiation	4/157	128/8577	0.207132413609048	0.531194415545785	0.414968163087737	3552/7124/1513/7040	4
hsa04926	Relaxin signaling pathway	4/157	129/8577	0.21095428329704	0.532408429273482	0.415916548522151	1287/4313/7040/7423	4
hsa04540	Gap junction	3/157	88/8577	0.217944523086181	0.54145592454223	0.422984436252785	80310/5154/56034	3
hsa05020	Prion disease	7/157	272/8577	0.230870600129283	0.563381037601358	0.440112296835222	713/3552/7124/3915/714/6352/712	7
hsa05152	Tuberculosis	5/157	180/8577	0.233856279759054	0.563381037601358	0.440112296835222	3552/7124/1520/7040/1509	5
hsa05322	Systemic lupus erythematosus	4/157	137/8577	0.24220288497372	0.566864350704768	0.442833455035833	713/7124/714/712	4
hsa04810	Regulation of actin cytoskeleton	6/157	229/8577	0.242432552502668	0.566864350704768	0.442833455035833	2254/80310/5154/8817/2147/56034	6
hsa05150	Staphylococcus aureus infection	3/157	96/8577	0.256955310702388	0.592114411618545	0.462558759159142	713/714/712	3
hsa05231	Choline metabolism in cancer	3/157	98/8577	0.266864802109291	0.606164336219675	0.473534536073629	80310/5154/56034	3
hsa05134	Legionellosis	2/157	56/8577	0.273544145846105	0.612584777317333	0.478550173607714	7124/2920	2
hsa04916	Melanogenesis	3/157	101/8577	0.281811787048748	0.622334363065986	0.486166533212753	7483/54361/7474	3
hsa04072	Phospholipase D signaling pathway	4/157	148/8577	0.28670646612375	0.62447024813255	0.487835082950288	80310/5154/2147/56034	4
hsa04145	Phagosome	4/157	152/8577	0.303196017883507	0.651461714101048	0.50892076970489	1520/78989/1311/81035	4
hsa00310	Lysine degradation	2/157	63/8577	0.321086199229799	0.680702742367175	0.531763810654264	5352/8985	2
hsa04614	Renin-angiotensin system	1/157	23/8577	0.346531913457419	0.724981239996441	0.566354096786363	5476	1
hsa04664	Fc epsilon RI signaling pathway	2/157	68/8577	0.354604976140821	0.730233664154964	0.570457281498085	7124/3596	2
hsa05417	Lipid and atherosclerosis	5/157	215/8577	0.358227835245832	0.730233664154964	0.570457281498085	7124/8743/2920/6352/6348	5
hsa05164	Influenza A	4/157	171/8577	0.382404437861893	0.767228982481257	0.599357960495123	3552/7124/8743/6352	4
hsa04115	p53 signaling pathway	2/157	74/8577	0.394033796280364	0.767228982481257	0.599357960495123	3479/5054	2
hsa05163	Human cytomegalovirus infection	5/157	225/8577	0.39477738836047	0.767228982481257	0.599357960495123	7124/6351/6376/6352/6348	5
hsa04623	Cytosolic DNA-sensing pathway	2/157	75/8577	0.400503179534241	0.767228982481257	0.599357960495123	6351/6352	2
hsa05214	Glioma	2/157	75/8577	0.400503179534241	0.767228982481257	0.599357960495123	5154/3479	2
hsa04612	Antigen processing and presentation	2/157	78/8577	0.41971472415045	0.794460013570495	0.620630795109688	7124/1520	2
hsa01523	Antifolate resistance	1/157	30/8577	0.426030534945909	0.796927706545877	0.622558552614455	7124	1
hsa04068	FoxO signaling pathway	3/157	131/8577	0.431477085721892	0.797730891043963	0.623185998961851	3479/8743/7040	3
hsa04960	Aldosterone-regulated sodium reabsorption	1/157	37/8577	0.49591170996086	0.906321400962952	0.708016718395421	3479	1
hsa05330	Allograft rejection	1/157	38/8577	0.505178906862048	0.912766433989382	0.713051567101934	7124	1
hsa05219	Bladder cancer	1/157	41/8577	0.531976915265018	0.925845512662027	0.72326892084819	4313	1
hsa01522	Endocrine resistance	2/157	98/8577	0.538867215178822	0.925845512662027	0.72326892084819	3479/4313	2
hsa04750	Inflammatory mediator regulation of TRP channels	2/157	98/8577	0.538867215178822	0.925845512662027	0.72326892084819	3479/4803	2
hsa04932	Non-alcoholic fatty liver disease	3/157	155/8577	0.542978993915708	0.925845512662027	0.72326892084819	3552/7124/7040	3
hsa04934	Cushing syndrome	3/157	155/8577	0.542978993915708	0.925845512662027	0.72326892084819	7483/54361/7474	3
hsa04218	Cellular senescence	3/157	156/8577	0.547355208743588	0.925845512662027	0.72326892084819	3552/7040/5054	3
hsa04217	Necroptosis	3/157	159/8577	0.560337514351053	0.937005395966705	0.731987002476473	3552/7124/8743	3
hsa05161	Hepatitis B	3/157	162/8577	0.573095723019519	0.937005395966705	0.731987002476473	7124/3339/7040	3
hsa04930	Type II diabetes mellitus	1/157	46/8577	0.573472872219801	0.937005395966705	0.731987002476473	7124	1
hsa00514	Other types of O-glycan biosynthesis	1/157	47/8577	0.581322451291597	0.937005395966705	0.731987002476473	8985	1
hsa05166	Human T-cell leukemia virus 1 infection	4/157	222/8577	0.583418454092477	0.937005395966705	0.731987002476473	4316/3600/7124/7040	4
hsa04659	Th17 cell differentiation	2/157	108/8577	0.591859042913873	0.941055878233058	0.735151232250916	10148/7040	2
hsa00330	Arginine and proline metabolism	1/157	50/8577	0.604020239785016	0.94367435446411	0.737196781375472	5033	1
hsa04913	Ovarian steroidogenesis	1/157	51/8577	0.611311059810084	0.94367435446411	0.737196781375472	3479	1
hsa04979	Cholesterol metabolism	1/157	51/8577	0.611311059810084	0.94367435446411	0.737196781375472	51129	1
hsa04340	Hedgehog signaling pathway	1/157	56/8577	0.645812017252589	0.946363265680505	0.739297354189339	1954	1
hsa04935	Growth hormone synthesis, secretion and action	2/157	120/8577	0.649335203704025	0.946363265680505	0.739297354189339	3479/3483	2
hsa04071	Sphingolipid signaling pathway	2/157	121/8577	0.653825298291398	0.946363265680505	0.739297354189339	7124/1509	2
hsa04621	NOD-like receptor signaling pathway	3/157	186/8577	0.666610128494827	0.946363265680505	0.739297354189339	7124/2920/6352	3
hsa04611	Platelet activation	2/157	124/8577	0.667022765166646	0.946363265680505	0.739297354189339	2147/2244	2
hsa04730	Long-term depression	1/157	60/8577	0.671207490130747	0.946363265680505	0.739297354189339	3479	1
hsa05416	Viral myocarditis	1/157	60/8577	0.671207490130747	0.946363265680505	0.739297354189339	284217	1
hsa05132	Salmonella infection	4/157	249/8577	0.673540473376505	0.946363265680505	0.739297354189339	7124/8743/6281/302	4
hsa05206	MicroRNAs in cancer	5/157	310/8577	0.675869212729368	0.946363265680505	0.739297354189339	7148/5154/4325/3371/6768	5
hsa04213	Longevity regulating pathway - multiple species	1/157	61/8577	0.677268359456739	0.946363265680505	0.739297354189339	3479	1
hsa05167	Kaposi sarcoma-associated herpesvirus infection	3/157	194/8577	0.694289935860718	0.946363265680505	0.739297354189339	285/9976/2920	3
hsa04929	GnRH secretion	1/157	64/8577	0.694792860233378	0.946363265680505	0.739297354189339	6696	1
hsa04650	Natural killer cell mediated cytotoxicity	2/157	132/8577	0.700246538179978	0.946363265680505	0.739297354189339	7124/8743	2
hsa05130	Pathogenic Escherichia coli infection	3/157	198/8577	0.707471543201181	0.946363265680505	0.739297354189339	7124/2147/8743	3
hsa05010	Alzheimer disease	6/157	384/8577	0.711234882484224	0.946363265680505	0.739297354189339	3552/102/7124/7483/54361/7474	6
hsa04915	Estrogen signaling pathway	2/157	137/8577	0.719593192612017	0.946363265680505	0.739297354189339	4313/1509	2
hsa04920	Adipocytokine signaling pathway	1/157	69/8577	0.721923627231741	0.946363265680505	0.739297354189339	7124	1
hsa05415	Diabetic cardiomyopathy	3/157	203/8577	0.723336750749812	0.946363265680505	0.739297354189339	4313/7040/1509	3
hsa04371	Apelin signaling pathway	2/157	139/8577	0.72703481079732	0.946363265680505	0.739297354189339	5054/6696	2
hsa04622	RIG-I-like receptor signaling pathway	1/157	71/8577	0.7320923376019	0.946363265680505	0.739297354189339	7124	1
hsa03320	PPAR signaling pathway	1/157	75/8577	0.751334403677391	0.952039388699391	0.74373153172147	51129	1
hsa05212	Pancreatic cancer	1/157	76/8577	0.755926323063729	0.952039388699391	0.74373153172147	7040	1
hsa05220	Chronic myeloid leukemia	1/157	76/8577	0.755926323063729	0.952039388699391	0.74373153172147	7040	1
hsa05412	Arrhythmogenic right ventricular cardiomyopathy	1/157	77/8577	0.760433977137249	0.952039388699391	0.74373153172147	284217	1
hsa04514	Cell adhesion molecules	2/157	158/8577	0.789747063878148	0.967904008095916	0.756124945086515	1462/6383	2
hsa03083	Polycomb repressive complex	1/157	84/8577	0.789753755734422	0.967904008095916	0.756124945086515	3054	1
hsa04012	ErbB signaling pathway	1/157	85/8577	0.793640328247044	0.967904008095916	0.756124945086515	3084	1
hsa05210	Colorectal cancer	1/157	86/8577	0.797455503525566	0.967904008095916	0.756124945086515	7040	1
hsa04211	Longevity regulating pathway	1/157	89/8577	0.808485561472831	0.973857608137728	0.76077588719134	3479	1
hsa04658	Th1 and Th2 cell differentiation	1/157	92/8577	0.818918568508988	0.975677587602629	0.762197652016619	3596	1
hsa04912	GnRH signaling pathway	1/157	93/8577	0.822269161878946	0.975677587602629	0.762197652016619	4313	1
hsa04914	Progesterone-mediated oocyte maturation	1/157	102/8577	0.84978297268093	0.99109698823974	0.774243261253157	3479	1
hsa04625	C-type lectin receptor signaling pathway	1/157	104/8577	0.855297306773419	0.99109698823974	0.774243261253157	7124	1
hsa04931	Insulin resistance	1/157	108/8577	0.865729717192727	0.99109698823974	0.774243261253157	7124	1
hsa05202	Transcriptional misregulation in cancer	2/157	193/8577	0.872874934633994	0.99109698823974	0.774243261253157	5154/3479	2
hsa04670	Leukocyte transendothelial migration	1/157	115/8577	0.88221950797756	0.99109698823974	0.774243261253157	4313	1
hsa04722	Neurotrophin signaling pathway	1/157	119/8577	0.890721681328199	0.99109698823974	0.774243261253157	4803	1
hsa04152	AMPK signaling pathway	1/157	121/8577	0.894741179463626	0.99109698823974	0.774243261253157	3479	1
hsa04660	T cell receptor signaling pathway	1/157	121/8577	0.894741179463626	0.99109698823974	0.774243261253157	7124	1
hsa04919	Thyroid hormone signaling pathway	1/157	121/8577	0.894741179463626	0.99109698823974	0.774243261253157	54361	1
hsa05207	Chemical carcinogenesis - receptor activation	2/157	212/8577	0.904221650141741	0.99109698823974	0.774243261253157	2254/8817	2
hsa04114	Oocyte meiosis	1/157	131/8577	0.912738505548137	0.99109698823974	0.774243261253157	3479	1
hsa05135	Yersinia infection	1/157	137/8577	0.922032356848855	0.99109698823974	0.774243261253157	7124	1
hsa05162	Measles	1/157	138/8577	0.923482702817425	0.99109698823974	0.774243261253157	3552	1
hsa04140	Autophagy - animal	1/157	141/8577	0.927674838578783	0.99109698823974	0.774243261253157	1509	1
hsa05022	Pathways of neurodegeneration - multiple diseases	5/157	476/8577	0.941360467103058	0.99109698823974	0.774243261253157	3552/7124/7483/54361/7474	5
hsa05131	Shigellosis	2/157	247/8577	0.943996129051012	0.99109698823974	0.774243261253157	7124/6352	2
hsa04110	Cell cycle	1/157	157/8577	0.946465580388098	0.99109698823974	0.774243261253157	7040	1
hsa05160	Hepatitis C	1/157	158/8577	0.947463787499626	0.99109698823974	0.774243261253157	7124	1
hsa04141	Protein processing in endoplasmic reticulum	1/157	170/8577	0.958092652129426	0.993548620761319	0.776158472359057	55768	1
hsa05014	Amyotrophic lateral sclerosis	3/157	364/8577	0.965800200382154	0.993548620761319	0.776158472359057	7124/310/3084	3
hsa04613	Neutrophil extracellular trap formation	1/157	191/8577	0.971806154556043	0.993548620761319	0.776158472359057	2244	1
hsa05169	Epstein-Barr virus infection	1/157	202/8577	0.977101123623423	0.993548620761319	0.776158472359057	7124	1
hsa05170	Human immunodeficiency virus 1 infection	1/157	212/8577	0.981051153833503	0.993548620761319	0.776158472359057	7124	1
hsa05016	Huntington disease	1/157	306/8577	0.996839753556712	0.999022428767695	0.780434601751659	7052	1
hsa04080	Neuroactive ligand-receptor interaction	1/157	367/8577	0.999022428767695	0.999022428767695	0.780434601751659	2147	1
